A detailed history of West Branch Capital LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, West Branch Capital LLC holds 83 shares of NVO stock, worth $8,518. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83
Previous 78 6.41%
Holding current value
$8,518
Previous $11,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$119.07 - $145.42 $595 - $727
5 Added 6.41%
83 $9,000
Q3 2023

Oct 20, 2023

BUY
$90.94 - $199.54 $3,546 - $7,782
39 Added 100.0%
78 $7,000
Q1 2023

Apr 20, 2023

SELL
$132.34 - $159.14 $10,057 - $12,094
-76 Reduced 66.09%
39 $6,000
Q2 2021

Aug 17, 2021

BUY
$67.66 - $84.76 $7,780 - $9,747
115 New
115 $9,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track West Branch Capital LLC Portfolio

Follow West Branch Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Branch Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Branch Capital LLC with notifications on news.